Two important
protein-
protein interactions establish
E-cadherin (Cdh1) in the adhesion complex; homophilic binding via the extra-cellular (EC1) domain and cytoplasmic tail binding to β-
catenin. Here, we evaluate whether
E-cadherin binding can inhibit β-
catenin when there is loss of
Adenomatous polyposis coli (APC) from the β-
catenin destruction complex. Combined conditional loss of Cdh1 and Apc were generated in the intestine, intestinal
adenoma and
adenoma organoids. Combined intestinal disruption (Cdh1fl/flApcfl/flVil-CreERT2) resulted in lethality, breakdown of the intestinal barrier, increased Wnt target gene expression and increased nuclear β-
catenin localization, suggesting that
E-cadherin inhibits β-
catenin. Combination with an intestinal stem cell Cre (Lgr5CreERT2) resulted in ApcΔ/Δ recombination and
adenoma, but intact Cdh1fl/fl alleles. Cultured ApcΔ/ΔCdh1fl/fl
adenoma cells infected with adenovirus-Cre induced Cdh1fl/fl recombination (Cdh1Δ/Δ), disruption of organoid morphology, nuclear β-
catenin localization, and cells with an epithelial-mesenchymal phenotype. Complementation with adenovirus expressing wild-type Cdh1 (Cdh1-WT) rescued adhesion and β-
catenin membrane localization, yet an EC1 specific double mutant defective in homophilic adhesion (Cdh1-MutW2A, S78W) did not. These data suggest that
E-cadherin inhibits β-
catenin in the context of disruption of the APC-destruction complex, and that this function is also EC1 domain dependent. Both binding functions of
E-cadherin may be required for its tumour suppressor activity.